Publication | Open Access
Canakinumab in adults with steroid‐refractory pyoderma gangrenosum
108
Citations
23
References
2015
Year
Our data indicate that IL-1β plays a key pathogenic role in PG and canakinumab may represent a therapeutic option for steroid-refractory PG.
| Year | Citations | |
|---|---|---|
Page 1
Page 1